Jacob Ph.d Vanlandingham - 10 Jun 2022 Form 4 Insider Report for Odyssey Health, Inc. (ODYY)

Role: VP of Drug Development
Signature: /s/ Christine M. Farrell, Attorney-in-Fact for Jacob Vanlandingham
Issuer symbol: ODYY
Transactions as of: 10 Jun 2022
Net transactions value: +$230,000
Form type: 4
Filing time: 14 Jun 2022, 16:10:46 UTC
Previous filing: 08 Jun 2022
Next filing: 19 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ODYY	ODYY common stock $0.001 par value	Award	$230,000	+1,000,000	+12%	$0.2300	9,660,000	10 Jun 2022	By Prevacus, Inc.

* An asterisk sign (*) next to the price indicates that the price is likely invalid.